The trajectory of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the patent expiration in key regions has introduced considerable volatility. Investors are now facing the effect of rival medica